Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

A possible benchmark for Barrett’s esophagus surveillance

Publish date:: October 8, 2020

Key clinical point: Missed dysplasia or esophageal adenocarcinoma could lead to greater disease burden.

Major finding: The neoplasia detection rate was 4.9%.

Study details: A retrospective analysis of data from 11 counties in Minnesota (1,066 patients).

Disclosures: The study was funded by the National Cancer Institute and the National Institute of Aging. Dr. Mosko has no relevant financial disclosures.

Citation:

Dhaliwal L et al. Clin Gastro Hepatol. 2020 Jul 21. doi: 10.1016/j.cgh.2020.07.034.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

IBD patients prefer vedolizumab over anti-TNF drugs,

During pandemic, many gastroenterologists report low resilience, insomnia,